Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells
about
sameAs
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tractPathogenesis of human immunodeficiency virus infectionFollicular dendritic-like cells derived from human monocytesAre T cells the only HIV-1 reservoir?Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interactionV3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryImmune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytesDecreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissueDendritic-cell interactions with HIV: infection and viral dissemination.Acute SIV infection in sooty mangabey monkeys is characterized by rapid virus clearance from lymph nodes and absence of productive infection in germinal centers.Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathwayCD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in PathogenesisDistinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.Divergent T-cell cytokine patterns in inflammatory arthritisTreatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infectionIn situ hybridization AT-tailing with catalyzed signal amplification for sensitive and specific in situ detection of human immunodeficiency virus-1 mRNA in formalin-fixed and paraffin-embedded tissues.Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection.Rapid shift from virally infected cells to germinal center-retained virus after HIV-2 infection of macaques.Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patientsPostmortem localization of HIV-1 RNA by in situ hybridization in lymphoid tissues of intravenous drug addicts who died unexpectedlyWhite pulp reconstitution after human bone marrow transplantation.An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeysAnalysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution.Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosisThe immunocompromised host: HIV infection.Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapyImmunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).TFH in HIV Latency and as Sources of Replication-Competent VirusContribution of follicular dendritic cells to persistent HIV viremia.Altering cell death pathways as an approach to cure HIV infection.Defining HIV and SIV Reservoirs in Lymphoid Tissues.Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining.Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
P2860
Q22242965-E4482501-6DB6-4B73-B460-F13320D84F98Q24634681-DB3D5966-90DA-4417-BA1B-9CD4AC620C9AQ24816800-7ED919F7-8BFC-46BE-A858-3DE55BF7C496Q28078850-FA034572-62EF-4169-8F5A-7315C1FB8381Q33490680-28BBD1F8-BE6B-4B47-8465-737D317A790CQ33646010-3079699B-89CF-43A1-A35E-4E41CF6BF84BQ33653627-5F619C53-B2A5-4318-B2C1-7866BCBB708DQ33742139-8D32B07B-6225-4DAA-82C4-9585A82517DCQ33795645-898052A0-A25C-4352-A569-0FE960046AAFQ34176667-B297A7B5-FBE1-4A98-9119-EA5CF47F6328Q34572043-73B586AC-F3D2-4088-9C5A-520486E7E9FEQ34614475-3FDAA3B0-6D95-492E-A724-8112E8EBAFA0Q34720373-A09CC12D-0E86-4535-BFE7-B26535E9F756Q34815328-6BEEAD76-F5B8-41DB-AF81-EE8C3189E428Q34841938-3BA76E49-6DEB-4A07-A419-03BD186BB26AQ35143430-A6822578-1699-4CBA-817C-BEDDBAED71ACQ35382501-4D413260-1DD9-4675-AA5C-37EA005A0146Q35729900-B6D98903-29BB-470A-9640-1A41684A9565Q35745547-257D80DF-502E-47F7-8D51-4DF7BA07F78CQ35749016-D60FB967-CE84-4453-8701-A3BE2101B6DEQ35764050-F7C0537C-EFB3-4626-B51A-A4911ED0DF39Q35809958-5697DA2F-F1BD-4617-A751-7DA802FB4B5AQ35833022-0301CAA1-BEB3-4CBA-99F1-345304E32D2EQ35833038-DB809954-1102-4E26-882C-512A4305AEF5Q35833207-ACC7E3AE-2621-43FC-AF73-DAA011C1EF5AQ35860563-DD96823F-9C53-4E6C-ABDD-D686084B8507Q36048710-0F8FD3C2-E3CF-4CFE-B91B-DD57863A5D0DQ36231815-551A4905-466C-4139-90B7-3D28EEDBF70DQ36328685-149300E6-84F1-4616-B31B-F6E638EBF532Q36362448-92E92325-D462-4846-BB0C-1C6FD1E16966Q36368837-AA3F26F4-12BA-4947-B281-79B144EE1624Q36400457-85B4F91F-F869-48D0-B7DB-6A111B173E13Q36631918-6B81A9BB-C765-4F4C-B2C0-61BCD7C082F6Q36645449-52654AA0-F8B7-4208-A7FC-E013C0BB3E68Q36827343-51170387-8A38-439A-A3A2-42137A34D887Q36978662-67BABA4D-8CC1-48BA-88C2-40054961342EQ37062057-1A77387F-001D-4023-B3EB-562DB0C85A52Q37090999-115B6A59-4A64-4047-9269-8EC54F749505Q37107753-DAAD5F63-309B-452E-972B-9B45D6515D25Q37176054-A19BE15B-877A-4F3E-A9CE-3D5691712BC4
P2860
Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@ast
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@en
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@nl
type
label
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@ast
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@en
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@nl
prefLabel
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@ast
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@en
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@nl
P2093
P2860
P1476
Follicular dendritic cells are ...... fection of CD4+ T-helper cells
@en
P2093
P2860
P407
P577
1992-01-01T00:00:00Z